A side effect of this popular diabetes and weight loss drug

New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
FDA adds new warning to weight loss drugs including Wegovy
The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into their lungs while under anesthesia.
Counterfeit market emerges for popular weight-loss drugs
With the rise in the popularity of weight loss drugs like ‘Wegovy’ and ‘Ozempic,’ we’re learning a counterfeit market has also emerged which could be endangering people’s lives. Global pharmaceutical company Novo Nordisk alone brought in 21 billion dollars in revenue last year from drugs like Ozempic,
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries
Wegovy and other weight loss drugs shows promise for heart disease
A new clinical trial found that weight-loss drug Wegovy shows promise for lowering the risk of heart attack and stroke among people with heart disease and obesity.
Weight-loss drugs just got cheaper — and better
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.
Ozempic butt: A side effect of this popular diabetes and weight loss drug
Ozempic has been talk of the town for a while now, not only for helping people with diabetes, but also for working as a weight loss drug. Global celebrities like Amy Schumer, Sharon Osbourne, and Kathy Bates have admitted to using this medication to drop extra pounds.
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
MedPage Today17h
ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs
Oral Semaglutide Meets Endpoints at Lower Dose A once-daily 25-mg oral dose of semaglutide resulted in greater weight ...
Counterfeit weight loss drugs sold online, feeding demand for cheaper options
Real weight-loss medication pens should have unique identification codes ... Novo Nordisk, the maker of Ozempic, Rybelsus and Wegovy, said in a statement to CBS News: "It's important that ...
Medscape5h
Oral Semaglutide 25-mg Dose May Provide Most Benefit
SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...
Has semaglutide transformed treatment of diabetes and obesity in India?
So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...
Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down while saving money.
KSL7d
Don't want the side effects of the shots? Best alternative to Semaglutide and other drugs
Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...
WXYZ4d
FDA adds new warning to popular weight loss drugs
(WXYZ) — The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. A new ...